1. Home
  2. FTK vs LXEO Comparison

FTK vs LXEO Comparison

Compare FTK & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTK
  • LXEO
  • Stock Information
  • Founded
  • FTK 1985
  • LXEO 2017
  • Country
  • FTK United States
  • LXEO United States
  • Employees
  • FTK N/A
  • LXEO N/A
  • Industry
  • FTK Major Chemicals
  • LXEO
  • Sector
  • FTK Industrials
  • LXEO
  • Exchange
  • FTK Nasdaq
  • LXEO Nasdaq
  • Market Cap
  • FTK 336.2M
  • LXEO 290.5M
  • IPO Year
  • FTK N/A
  • LXEO 2023
  • Fundamental
  • Price
  • FTK $16.45
  • LXEO $8.20
  • Analyst Decision
  • FTK Buy
  • LXEO Strong Buy
  • Analyst Count
  • FTK 2
  • LXEO 7
  • Target Price
  • FTK $12.00
  • LXEO $15.29
  • AVG Volume (30 Days)
  • FTK 513.6K
  • LXEO 763.8K
  • Earning Date
  • FTK 11-03-2025
  • LXEO 11-12-2025
  • Dividend Yield
  • FTK N/A
  • LXEO N/A
  • EPS Growth
  • FTK 82.12
  • LXEO N/A
  • EPS
  • FTK 0.43
  • LXEO N/A
  • Revenue
  • FTK $214,211,000.00
  • LXEO N/A
  • Revenue This Year
  • FTK $19.47
  • LXEO N/A
  • Revenue Next Year
  • FTK $11.22
  • LXEO N/A
  • P/E Ratio
  • FTK $41.21
  • LXEO N/A
  • Revenue Growth
  • FTK 21.72
  • LXEO N/A
  • 52 Week Low
  • FTK $4.70
  • LXEO $1.45
  • 52 Week High
  • FTK $17.89
  • LXEO $11.72
  • Technical
  • Relative Strength Index (RSI)
  • FTK 65.74
  • LXEO 83.09
  • Support Level
  • FTK $15.02
  • LXEO $6.33
  • Resistance Level
  • FTK $17.93
  • LXEO $6.90
  • Average True Range (ATR)
  • FTK 1.10
  • LXEO 0.55
  • MACD
  • FTK 0.37
  • LXEO 0.14
  • Stochastic Oscillator
  • FTK 73.18
  • LXEO 85.01

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: